EGFR and lung adenocarcinoma: A 58-year-old female patient (case NCCLu-045) with stage IV lung adenocarcinoma harboring EGFR L858R received two EGFR-TKIs (erlotinib and olmutinib) and multiple rounds of chemotherapy.